Whether you agree from it in principle or not, testing for illicit drug use is a reality for many people workers in the Western. Drug testing is mandatory for federal employees, and although it’s required in the private sector, more employers are implementing some kind(s) of drug screening.
When drug testing is mandated, employers almost always follow the SAMHSA (Substance Abuse and Mental Health Services Administration) guidelines since the device puts them on solid legal ground. Typically, there is an overlap between testing guidelines and accepted cutoff levels for drugs and drug metabolites in confirmatory testing and screening.
Because THC is more popular as being responsible for marijuana’s psychoactivity and euphoria, a routine urine drug screen for marijuana use consists of an immunoassay with antibodies that will detect it, and its main metabolite, 11-nor-delta9-caboxy-THC (THC-COOH). SAMHSA has set the cutoff level for a positive urine screen in the immunoassay at 50 ng/mL. When the immunoassay screen is positive at the > 50 ng/mL level, a confirmatory GC/MS (Gas Chromatography/Mass Spectrometry) test is performed to verify the positive urine screen. The confirmatory GC/MS has a cutoff level of 15 ng/mL and is specific and the 11-nor-THCCOOH metabolite.
Fortunately, the urine drug screen for THC-COOH might have very little cross-reactivity to other cannabinoids that are not psychoactive, such as CBD (cannabidiol), CBG (cannabigerol), CBN (cannabinol), and others. Many . good news for normal consumers of Wholesale CBD Isolate.
That said, individuals using unusually large doses within the cannabinoid-rich hemp oil product (above 1000-2000 mg of hemp oil daily) could theoretically test positive in initial urinary screen. Although very rare, the urine screen in these cases would likely represent a false positive due to other non-THC metabolites or compounds, which may cross-react without the pain . immunoassay. When this may be the case, the confirmatory GC/MS test would be negative, since CBD and other cannabinoids will not be detected by the more accurate (and specific) GC/MS touch screen.
Keep in mind that most of the high-quality, reliable CBD-rich hemp oil products contain much less THC than marijuana. For example, hemp contains anywhere from 1/10th to 1/300th among the THC concentration found in marijuana. An individual consuming 1000-2000 mg per day’s hemp oil would thus consume approximately 3-6 mg of THC. This exceedingly high dose may cause detection of positive urine screen in up to 11% to 23% of assays.
On the other hand, there is some data demonstrating that at daily doses of 0.5mg of THC from 3-5 servings of most commercial CBD-rich hemp oil products, good urine screen rates are < 0.2%. Again, most servings of typical high-quality, high-purity CBD-based hemp oil products contain well below 0.1mg of THC and therefore have over 400-600 times less THC than marijuana materials. What does all this mean? Put simply, a consumer who uses a high-quality, scientifically vetted hemp-based product at although serving size is highly unlikely to test positive for THC and/or THC-COOH. However, it’s important end up being cognizant that higher than normal doses may result in a positive urine screen (that would be subsequently shown for you to become false via GC/MS). Ultimately, consumers want to be fully informed of your specific regulations caused from their employers and adjust their consumption of cannabinoid products accordingly.